Documentos de Carmen Elena Viada | REDI

Regresar

Mostrando 6 resultados de: 6

Filtros aplicados

Área de conocimiento: "Farmacología"

Subtipo de publicación

Publisher

Acta Farmaceutica Bonaerense(1)

Biotecnologia Aplicada(1)

VacciMonitor(1)

Área temáticas

Enfermedades(5)

Farmacología y terapéutica(4)

Medicina y salud(2)

Funcionamiento de bibliotecas y archivos(1)

Área de conocimiento

Año de Publicación

Origen

Palabras Claves

Clinical trial(2)

Non-small cell lung cancer(2)

immunotherapy(2)

Evaluation of CIMAvaxEGF for the treatment of lung cancer: Meta-analysis of controlled clinical trials

Abstract: CIMAvaxEGF is a therapeutic cancer vaccine developed in Cuba and fully licensed in the country for u

Palabras claves:

EGF receptor, Epidermal growth factor, immunotherapy, Of non-small cell lung cancer vaccine therapy, Oncology vaccines

Aliuska Frías, Ballesteros J., Bárbara Wilkinson, Camilo Rodríguez, Carmen Elena Viada, Mabel Álvarez, Martha M. Fors-López, Neninger Vinageras E., Quintero J., Robaina M., Tania Crombet

Evaluation of racotumomab for the treatment of lung cancer: Meta-analysis of controlled trials of the CIM

Abstract: Racotumomab is a therapeutic cancer vaccine entirely developed in Cuba and licensed in the country f

Palabras claves:

immunotherapy, Non-small cell lung cancer, Oncological vaccines, Racotumomab, Vaccinal treatment

Alfonso S., Aliuska Frías, Ballesteros J., Carmen Elena Viada, Hernández M., Mabel Álvarez, Macías A.E., Martha M. Fors-López, Quintero J., Robaina M.

Effect and safety of ribofen in rheumatoid arthritis treatment

Abstract: Rheumatoid arthritis (RA) is a chronic inflammatory and systemic disease, that it makes evident in t

Palabras claves:

Clinical trial, Rheumatoid Arthritis, Ribofen

Alvarez A., Carmen Elena Viada, Guevara-García M., López G., Riaño A., Rivera I., Uranga R.

Nimotuzumab for the treatment of patients with malignant glioma. Comparison between pre-registration and post-approved studies

Abstract: Nimotuzumab is a monoclonal antibody targeted against the epidermal growth factor receptor approved

Palabras claves:

And High-grade glioma, Controlled clinical studies, nimotuzumab, Postmarking studies, Target therapies

Aliuska Frías, Carmen Elena Viada, García L., Luaces P.L.o., Mabel Álvarez, Macías A.E., Santiesteban Y., Saurez G., Tania Crombet

Safety of racotumomab in the treatment of patients with non-small cell lung cancer

Abstract: In Cuba, lung cancer ranks second in incidence and first in mortality. Therefore, it is necessary to

Palabras claves:

Adverse events, Clinical trial, Non-small cell lung cancer, Racotumomab

Carmen Elena Viada, Estevez D., Gastón Y., Macías A.E., Pérez Ruiz L.

The role of Pharmacometrics in the development of Cuban Biotechnology products

Abstract: Pharmacometrics is a vibrant scientific discipline that involves a cycle of excellence: integration,

Palabras claves:

nimotuzumab, NONMEM, Pegylated erythropoietin, pharmacodynamics, pharmacokinetics, Pharmacometrics

Amaro D., Bécquer M.d.l.A., Carmen Elena Viada, Castañeda G., Colom H., de Castro Suárez N., Duconge J., Fernández G.R., Fernández-Sánchez E.M., Menéndez R., Sanjuan V.M., Solazábal J., Suzarte M.R., Vélez B.J., Vera L.R.